David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 30,000 shares at $36.92 ($1.1M) on 2021-09-07, disclosed to the SEC on 2021-09-09.
Open-market sale of $1.1M PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.91 | 7,487 | $269K | 24.4% |
| 2 | $35.91 | 7,487 | $269K | 24.4% |
| 3 | $36.92 | 2,873 | $106K | 9.6% |
| 4 | $36.92 | 2,873 | $106K | 9.6% |
| 5 | $37.79 | 4,640 | $175K | 15.9% |
| 6 | $37.79 | 4,640 |
| $175K |
| 15.9% |
| Total | $36.68 avg | 30,000 | $1.1M | 100% |
| Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |
| PRLD | SELL | 2021-05-10 | $1.2M | — | Filing → |